Eiko Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

8.32

8.32

3.82

3.82

3.82

Share application money

-

-

6.34

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

21.11

20.31

2.37

1.66

1.61

Loan funds

Secured loans

-

4.55

1.76

0.20

0.26

Unsecured loans

-

-

-

-

-

Total

29.42

33.18

14.28

5.68

5.69

Uses of funds

Fixed assets

Gross block

15.34

15.12

0.52

0.52

0.52

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1.46

0.83

0.27

0.21

0.14

Net block

13.88

14.29

0.25

0.31

0.37

Capital work-in-progress

-

-

-

-

-

Investments

0.05

0.20

0.22

0.50

2.13

Net current assets

Current assets, loans & advances

17.11

20.40

16.15

4.95

3.27

Less : current liabilities & provisions

1.62

1.71

2.33

0.08

0.08

Total net current assets

15.49

18.69

13.82

4.87

3.19

Miscellaneous expenses not written

-

-

-

-

-

Total

29.42

33.18

14.28

5.68

5.69

Notes:

Book value of unquoted investments

0.05

-

-

-

1.53

Market value of quoted investments

-

0.20

0.23

0.10

0.20

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

83.16

83.16

38.20

38.20

38.20